Vista Investment Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,150
Closed -$224K 182
2023
Q4
$224K Buy
+5,150
New +$203K 0.1% 158
2023
Q3
Sell
-5,512
Closed -$227K 160
2023
Q2
$227K Hold
5,512
0.11% 157
2023
Q1
$316K Hold
5,512
0.17% 130
2022
Q4
$309K Hold
5,512
0.18% 130
2022
Q3
$233K Hold
5,512
0.14% 143
2022
Q2
$298K Buy
5,512
+10
+0.2% +$601 0.18% 132
2022
Q1
$354K Hold
5,502
0.19% 124
2021
Q4
$369K Hold
5,502
0.2% 116
2021
Q3
$377K Hold
5,502
0.22% 110
2021
Q2
$375K Hold
5,502
0.22% 112
2021
Q1
$380K Sell
5,502
-30
-0.5% -$2.03K 0.24% 108
2020
Q4
$359K Hold
5,532
0.24% 106
2020
Q3
$261K Hold
5,532
0.2% 119
2020
Q2
$260K Hold
5,532
0.22% 116
2020
Q1
$247K Hold
5,532
0.25% 110
2019
Q4
$322K Hold
5,532
0.24% 108
2019
Q3
$332K Hold
5,532
0.27% 103
2019
Q2
$309K Buy
5,532
+382
+7% +$19.7K 0.26% 107
2019
Q1
$287K Hold
5,150
0.25% 109
2018
Q4
$232K Hold
5,150
0.24% 118
2018
Q3
$339K Hold
5,150
0.3% 105
2018
Q2
$332K Sell
5,150
-100
-2% -$6.19K 0.32% 104
2018
Q1
$291K Hold
5,250
0.3% 106
2017
Q4
$251K Buy
+5,250
New +$257K 0.26% 112

Other funds holding IART

Vista Investment Management's IART Position: Q1 2024 in Review

Vista Investment Management sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 5,150 shares — an estimated $224K sold.

Vista Investment Management first reported a position in IART in Q4 2017 and held it in 24 quarters. The position peaked at $380K in Q1 2021. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Vista Investment Management reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Vista Investment Management sold 5,150 Integra LifeSciences shares in Q1 2024, an estimated $224K.
  • Vista Investment Management first reported a position in Integra LifeSciences in Q4 2017 and held it in 24 quarters.
  • Vista Investment Management's Integra LifeSciences position peaked at $380K in Q1 2021.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Vista Investment Management's 13F filing for Q1 2024, filed 15 May 2024.